<DOC>
	<DOCNO>NCT01762514</DOCNO>
	<brief_summary>RATIONALE - Radiotherapy primary therapeutic strategy nasopharyngeal carcinoma . - Radiotherapy may cause adverse effect xerostomia mucositis . - Amifostine ability protect normal tissue also side effect . PURPOSE - This phase II trial study protect effect safety different Amifostine regimens patient nasopharyngeal carcinoma .</brief_summary>
	<brief_title>A Phase II Clinical Trial Comparison Effectiveness Safeness Different Amifostine Regimens</brief_title>
	<detailed_description>RATIONALE : Nasopharyngeal carcinoma kind malignant tumor treat primarily radiation therapy . This therapeutic strategy often cause adverse effect dysfunction salivary gland lesion oral mucosa . With concurrent chemotherapy , may also cause toxicity kidney , bone marrow , organs tissue . When administer prior chemoradiotherapy , Amifostine prove ability protect normal adverse effect improve patient tolerance . However , also side effect Amifostine , nausea , vomit hypotension , especially high dose apply . PURPOSE : This phase II randomize control trial study protect effect safety Amifostine every-other-day regimen compare standard everyday regimen adverse effect myelosuppression , xerostomia mucositis , patient nasopharyngeal carcinoma Stage T1-T4 , N0-N3 , M0 undergo concurrent chemoradiotherapy .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Salivary Gland Diseases</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>Nasopharyngeal cancer patient diagnose pathology cytology UICC/AJCC 2010 Stage T14 N03 M0 Male female patient age 18 75 year old Karnofsky Performance Scores ≥ 60 Expected survival ≥ 3 month Without dysfunction heart , lung , liver , kidney hematopoiesis No previous allergic reaction drug History alcohol drug abuse within 3 month Pregnant lactating woman Currently treatment similar drug Antihypertension drug apply less 24 hour Severe hypocalcemia Dysfunction heart , lung , liver , kidney hematopoiesis Severe neurological , mental endocrine diseases Previous allergic reaction drug Patients participate clinical trial drug within last 3 month Other unsuitable reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Nasopharyngeal carcinoma</keyword>
	<keyword>Amifostine</keyword>
	<keyword>Myelosuppression</keyword>
	<keyword>Xerostomia</keyword>
	<keyword>Mucositis</keyword>
</DOC>